netFormulary
 Report : A-Z CDF items in Formulary 03/03/2021 11:15:04
[Back]
 
Section Status CDF Name
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Zytiga®
08.01.05 Non Formulary Cancer Drugs Fund Aflibercept Zaltrap®
08.02.03 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
08.01.01 Formulary Cancer Drugs Fund Bendamustine Levact®
08.01.05 Restricted Use Cancer Drugs Fund Bevacizumab Avastin®
08.01.05 Restricted Use Cancer Drugs Fund Bevacizumab Avastin®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana®
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cometriq®
08.01.05 Formulary Cancer Drugs Fund Ceritinib Zykadia®
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
08.01.05 Non Formulary Cancer Drugs Fund Cisplatin 
08.01.03 Formulary Cancer Drugs Fund Clofarabine Evoltra®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar®
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex®
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel®
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx®
08.01 Formulary Cancer Drugs Fund Durvalumab Imfinzi®
08.03.04.02 Formulary Cancer Drugs Fund Enzalutamide Xtandi®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven®
08.01.05 Formulary Cancer Drugs Fund Everolimus 
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica®
08.01.05 Formulary Cancer Drugs Fund Imatinib Gilvec®
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy®
08.02.04 Formulary Cancer Drugs Fund Lenalidomide Revlimid®
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance®
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo®
08.01.05 Formulary Cancer Drugs Fund Olaratumab Lartruvo®
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix®
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid®
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig®
08.03.04.02 Formulary Cancer Drugs Fund Radium-223 dichloride 
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga®
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar®
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent®
08.01.05 Non Formulary Cancer Drugs Fund Temsirolimus Torisel®
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab Herceptin®
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto®
Oxfordshire Clinical Commissioning Group